Get the Stockscreener App
9.67
2.45%
-0.23
Haleon Plc Adr stock is traded at $9.67, with a volume of 5.06M.
It is down -2.45% in the last 24 hours and up +5.32% over the past month.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
See More
Previous Close:
$9.90
Open:
$9.78
24h Volume:
5.06M
Relative Volume:
0.57
Market Cap:
$43.25B
Revenue:
$14.26B
Net Income/Loss:
$1.98B
P/E Ratio:
22.35
EPS:
0.4327
Net Cash Flow:
$2.47B
1W Performance:
+2.09%
1M Performance:
+5.32%
6M Performance:
-7.14%
1Y Performance:
+3.74%
1-Day Range:
$9.655
$9.7889
1-Week Range:
$9.43
$9.97
52-Week Range:
$8.71
$11.42
Haleon Plc Adr Stock (HLN) Company Profile
Compare HLN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLN
Haleon Plc Adr
|
9.665 | 44.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
ZTS
Zoetis Inc
|
121.33 | 53.39B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.32 | 44.99B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
25.54 | 29.30B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
465.65 | 19.91B | 3.08B | 1.24B | 1.07B | 25.61 |
Haleon Plc Adr Stock (HLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-16-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Sep-10-25 | Upgrade | Goldman | Neutral → Buy |
| May-27-25 | Upgrade | BNP Paribas Exane | Neutral → Outperform |
| May-09-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-05-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Aug-06-24 | Initiated | Berenberg | Buy |
| Aug-06-24 | Downgrade | Goldman | Buy → Neutral |
| Jun-05-24 | Initiated | Berenberg | Buy |
| Apr-17-24 | Initiated | HSBC Securities | Buy |
| Dec-11-23 | Resumed | Jefferies | Buy |
| Nov-01-23 | Initiated | Morgan Stanley | Overweight |
| May-24-23 | Initiated | Stifel | Hold |
| Apr-06-23 | Upgrade | Argus | Hold → Buy |
| Apr-04-23 | Initiated | Bernstein | Outperform |
| Dec-07-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-28-22 | Initiated | Argus | Hold |
View All
Haleon Plc Adr Stock (HLN) Latest News
Haleon (HLN) "Could be a Mini Kenvue," Says Jim Cramer - Finviz
Haleon discloses share acquisitions by senior executives under reward plan - Investing.com
Haleon (HLN.L) Share Price Today: UK Stock Climbs as Vindi Banga Named Chair — 11 November 2025 - ts2.tech
Assetmark Inc. Cuts Stock Position in Haleon PLC Sponsored ADR $HLN - Defense World
Acadian Asset Management LLC Acquires 5,212,711 Shares of Haleon PLC Sponsored ADR $HLN - Defense World
Haleon names Vindi Banga as new chair, succeeding Dave Lewis in January - Investing.com
Haleon appoints Vindi Banga as chair, Dave Lewis to step down - Investing.com Philippines
Haleon PLC Sponsored ADR (NYSE:HLN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Haleon reports total voting rights at 8.91 billion shares - Investing.com
Cambiar Investors LLC Sells 66,254 Shares of Haleon PLC Sponsored ADR $HLN - MarketBeat
37,653 Shares in Haleon PLC Sponsored ADR $HLN Bought by Earned Wealth Advisors LLC - MarketBeat
D.A. Davidson & CO. Trims Position in Haleon PLC Sponsored ADR $HLN - Defense World
HALEON ADR earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa
Haleon Earnings: US Remains Soft but Strong Oral Care Results Help Drive Solid Organic Growth - Morningstar
Haleon Sees Soft US Demand in 2025, but Innovation and Expansion Paint Favorable Long-Term Picture - Morningstar
Earnings call transcript: Haleon Q3 2025 misses EPS forecast, cautious market reaction By Investing.com - Investing.com South Africa
Haleon Q3 2025 slides: 3.4% organic growth despite regional disparities By Investing.com - Investing.com Australia
Haleon Q3 2025 slides: 3.4% organic growth despite regional disparities - Investing.com
Earnings call transcript: Haleon Q3 2025 misses EPS forecast, cautious market reaction - Investing.com
Haleon plc (HLN) Q3 2025 Sales/ Trading Statement CallSlideshow (NYSE:HLN) 2025-10-30 - Seeking Alpha
Envestnet Asset Management Inc. Purchases 476,823 Shares of Haleon PLC Sponsored ADR $HLN - MarketBeat
Bleakley Financial Group LLC Invests $671,000 in Haleon PLC Sponsored ADR $HLN - MarketBeat
Is Haleon plc (H6D0) stock nearing a technical breakoutEarnings Beat & Community Supported Trade Ideas - newser.com
Haleon PLC Sponsored ADR $HLN Stock Holdings Lifted by Allspring Global Investments Holdings LLC - Defense World
Haleon PLC Sponsored ADR (NYSE:HLN) Short Interest Update - MarketBeat
Yousif Capital Management LLC Boosts Holdings in Haleon PLC Sponsored ADR $HLN - Defense World
Drive Wealth Management LLC Increases Stock Holdings in Haleon PLC Sponsored ADR $HLN - MarketBeat
Haleon Balances Growth And Risks In Consumer Health - Finimize
Haleon Plc Adr Stock (HLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):